iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
2.060
-0.050 (-2.37%)
At close: Apr 17, 2026, 4:00 PM EDT
2.050
-0.010 (-0.49%)
After-hours: Apr 17, 2026, 7:59 PM EDT

iBio, Inc. Revenue

iBio, Inc. had revenue of $300.00K in the twelve months ending December 31, 2025, down -20.00% year-over-year. In the fiscal year ending June 30, 2025, iBio, Inc. had annual revenue of $400.00K with 77.78% growth.

Revenue (ttm)
$300.00K
Revenue Growth
-20.00%
P/S Ratio
237.20
Revenue / Employee
$15,000
Employees
20
Market Cap
71.16M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 2025400.00K175.00K77.78%
Jun 30, 2024225.00K--
Jun 30, 2023---
Jun 30, 20221.88M-487.00K-20.54%
Jun 30, 20212.37M733.00K44.75%
Jun 30, 20201.64M-380.00K-18.83%
Jun 30, 20192.02M1.57M354.50%
Jun 30, 2018444.00K50.00K12.69%
Jun 30, 2017394.00K-554.00K-58.44%
Jun 30, 2016948.00K-903.00K-48.78%
Jun 30, 20151.85M1.65M802.93%
Jun 30, 2014205.00K-802.00K-79.64%
Jun 30, 20131.01M-270.00K-21.14%
Jun 30, 20121.28M756.92K145.54%
Jun 30, 2011520.08K--
Jun 30, 2010---
Jun 30, 20091.18M189.54K19.20%
Jun 30, 2008987.06K90.79K10.13%
Jun 30, 2007896.27K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
ImmuCell27.64M
TScan Therapeutics10.33M
Immutep5.28M
BeyondSpring1.88M
MediciNova409.66K
Impact BioMedical32.00K
Revenue Rankings